GF
George Farmer Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
63.6%
Neutral
27.3%
Negative
9.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $10 |
580%
upside
| 1 | -7% |
0
%
| 6 Aug ‘25 7 months ago |
|
|
|
Sector Outperform
Maintained
| $133 |
16%
upside
| 2 | +44% |
0
%
| 31 Jul ‘25 7 months ago |
|
|
|
Sector Perform
Downgraded
| $9.20 |
6%
upside
| 1 | +28% |
–
| 8 Jul ‘25 8 months ago |
|
|
|
Sector Underperform
Downgraded
| $0.6000 |
53%
downside
| 1 | +45% |
0
%
| 1 Jul ‘25 8 months ago |
|
|
|
Sector Outperform
Maintained
| $47 |
142%
upside
| 1 | +76% |
0
%
| 13 Jun ‘25 9 months ago |
|
|
|
Sector Perform
Maintained
| $17 |
30%
downside
| 1 | – |
–
| 6 May ‘25 10 months ago |
|
|
|
Sector Outperform
Initiated
| $12 |
110%
upside
| 1 | +37% |
0
%
| 16 Apr ‘25 10 months ago |
|
|
|
Sector Perform
Downgraded
| $9 |
275%
upside
| 2 | -35% |
0
%
| 10 Apr ‘25 11 months ago |
|
|
|
Sector Outperform
Maintained
| $1.40 | – | 1 | -77% |
0
%
| 21 Mar ‘25 11 months ago |
|